Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5 32.75

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Caps

How do you think ARNA will perform against the market?

Add Stock to CAPS Watchlist

All Players

768 Outperform
75 Underperform
 

All-Star Players

104 Outperform
21 Underperform
 

Wall Street

8 Outperform
6 Underperform
 

Top ARNA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rteberg (< 20)
Submitted January 23, 2013

Weight loss drug will have great acceptance in the market

opgenortht (< 20)
Submitted April 22, 2010

obesity market for drugs without significant sustained weight loss - greater than 10% - is impossible to penetrate without gigantic consumer-directed, expensive, advertising....remember 10% for a 250lb person is 25lb bringing their new weight to… More

ARNA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ARNA.

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 11/24/2018 2:53:59 PM : Outperform Start Price: $40.60 ARNA Score: +5.84

price target raised by analysts at Credit Suisse Group AG from $56.00 to $61.00 on Monday. They now have an "outperform" rating on the stock. 51.4% upside from the current price of $40.29

Recs

0
Member Avatar Capitalism (80.42) Submitted: 9/19/2018 11:51:53 AM : Outperform Start Price: $41.93 ARNA Score: +11.22

bulwnkl from Saul's MF msg board

Recs

0
Member Avatar TMFEBCapital (80.70) Submitted: 2/15/2018 12:02:45 PM : Outperform Start Price: $39.94 ARNA Score: +9.34

Big potential catalyst on deck in the form of results from a mid stage trial evaluating a drug with the same mechanism of action as Celgene's ozanimod. If ARNA's trial is a success, shares are likely to trade meaningfully higher. A disappointment could cause a plunge, though, so buyer beware.

Leaderboard

Find the members with the highest scoring picks in ARNA.

Score Leader

bluemoth

bluemoth (63.68) Score: +757.14

The Score Leader is the player with the highest score across all their picks in ARNA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
PacificSexLegend 89.01 6/19/2009 Underperform 5Y $53.70 -21.17% +183.90% +205.07 0 Comment
bmswbc 90.74 12/1/2008 Underperform 3M $35.10 +20.60% +211.99% +191.39 0 Comment
ShortItNow 27.87 8/30/2006 Underperform 3M $118.90 -64.36% +113.64% +177.99 0 Comment
farhangp < 20 6/23/2017 Outperform 5Y $14.98 +182.62% +7.51% +175.11 0 Comment
marianeaj1 24.12 8/4/2010 9/14/2010 Underperform 3W $73.20 -42.17% +132.45% +174.62 0 Comment
mimiaj 87.41 8/4/2010 9/10/2010 Underperform 3W $73.20 -42.17% +132.45% +174.62 0 Comment
Sempre57 51.67 11/7/2006 Underperform 3M $155.70 -72.78% +101.03% +173.82 0 Comment
foolergo8888 30.21 8/3/2010 Underperform 5Y $69.00 -38.65% +132.55% +171.21 0 Comment
ozarksmart < 20 12/22/2006 Underperform 1Y $135.70 -68.77% +97.48% +166.25 0 Comment
lowrider61 45.14 12/4/2006 Underperform NS $130.60 -67.55% +98.62% +166.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackWallachBeth 41.94 11/15/2013 Outperform NS $54.10 -21.76% +45.68% -67.43 0 Comment
TrackUltraLong < 20 10/3/2012 Outperform NS $88.50 -52.17% +80.36% -132.53 1 Comment
TrackJimCramer 85.23 9/11/2012 Underperform 3W $79.90 -47.02% +81.76% +128.79 0 Comment
TrackCreditSuiss 88.67 9/6/2012 Underperform NS $89.20 -52.54% +84.52% +137.07 0 Comment
TrackZacks < 20 7/13/2012 Outperform 3M $111.80 -17.26% +6.14% -23.40 10/15/2012 @ $92.50 1 Comment
TrackJimCramer 85.23 6/11/2012 Outperform 3W $70.80 +12.85% +9.51% +3.35 9/12/2012 @ $79.90 0 Comment
TrackPoisedTo < 20 5/4/2012 Underperform 5Y $28.40 +49.05% +88.84% +39.79 0 Comment
TrackZacks < 20 3/27/2012 Outperform 3M $32.60 +205.98% -3.59% +209.57 6/30/2012 @ $99.75 1 Comment
TrackBarclaysCap 88.73 9/14/2010 Underperform NS $43.10 -1.79% +131.29% +133.08 0 Comment
TrackRodmanRen < 20 7/16/2010 Underperform NS $48.20 -12.18% +139.78% +151.96 0 Comment
TrackUBS 91.87 7/2/2010 Outperform NS $39.10 +8.26% +154.70% -146.44 0 Comment
TrackRodmanRen < 20 9/18/2009 Underperform NS $53.30 -36.96% +1.33% +38.29 2/4/2010 @ $33.60 0 Comment
TrackRodmanRen < 20 6/24/2009 Outperform NS $48.10 +1.88% +16.05% -14.18 9/15/2009 @ $49.00 0 Comment
TrackCanaccord 72.71 3/16/2009 Underperform NS $48.60 -12.90% +245.91% +258.81 0 Comment
TrackOppenheimer 70.85 12/1/2008 Outperform NS $38.00 +11.39% +206.86% -195.46 0 Comment
TrackLeerinkSwan 97.82 8/25/2008 Outperform NS $62.90 -20.83% -17.43% -3.39 9/21/2009 @ $49.80 0 Comment
TrackNeedham 90.31 8/6/2008 Outperform NS $65.00 -78.62% +3.80% -82.42 3/31/2011 @ $13.90 0 Comment
TrackSoros 85.15 3/31/2008 Outperform NS $68.40 -38.11% +105.55% -143.66 1 Comment
TrackUBS 91.87 2/28/2008 Outperform NS $70.40 -3.84% -42.19% +38.36 2/18/2009 @ $67.70 0 Comment
TrackBofASec 91.97 1/15/2008 Outperform NS $78.30 -45.94% +95.01% -140.95 0 Comment
TrackBMOCapital < 20 9/28/2007 Outperform NS $111.60 -11.82% -13.85% +2.03 6/25/2012 @ $98.41 0 Comment
TrackLazardCapit 76.65 2/23/2007 Outperform NS $139.00 -69.51% +91.15% -160.66 0 Comment
TrackJimCramer 85.23 2/15/2007 Underperform 3W $143.00 -50.52% -9.87% +40.66 6/11/2012 @ $70.75 0 Comment
TrackMorganJos 81.90 12/12/2006 Outperform NS $144.10 -70.59% +96.61% -167.20 0 Comment
TrackFortisBank < 20 10/25/2006 Outperform NS $160.00 -69.81% -22.09% -47.73 10/2/2008 @ $48.30 0 Comment
TrackAGEdwards < 20 9/15/2006 Outperform NS $112.70 +34.87% +4.55% +30.32 10/24/2006 @ $152.00 0 Comment
TrackJimCramer 85.23 3/16/2006 Outperform 3W $185.10 -22.74% +11.09% -33.84 2/16/2007 @ $143.00 0 Comment

Advertisement